Form 4: HCA Healthcare Director John Chidsey Receives Annual Equity Award
Insider Transaction Report
HCA Healthcare Director John Chidsey reported the acquisition of 496 restricted share units as part of an annual equity award, aligning his interests with shareholders.
Summary
- John Chidsey, a Director at HCA Healthcare, Inc. (HCA), acquired 496 shares of common stock on July 29, 2025.
- The acquisition represents common stock underlying 496 restricted share units (RSUs) granted as an annual director equity award.
- The RSUs were acquired at a price of $0, indicating they are a grant rather than a purchase.
- These RSUs are scheduled to vest on the sooner of the Issuer's 2026 annual shareholders' meeting or the first anniversary of the grant date.
- Following this transaction, John Chidsey directly beneficially owns 496 shares of common stock.
- Additionally, 3 shares are held indirectly by a managed account and 25 shares are held indirectly by a spouse, though the reporting person disclaims beneficial ownership of these shares except to the extent of pecuniary interest.
Sentiment
Score: 6
Explanation: The filing indicates a standard equity award to a director, which is generally a neutral to slightly positive event as it aligns director interests with shareholders. There are no negative implications.
Positives
- The grant of restricted share units to a director aligns management's interests with those of shareholders, promoting long-term value creation.
Future Outlook
The 496 restricted share units granted to Director John Chidsey are expected to vest on the sooner of the Issuer's 2026 annual shareholders' meeting or the first anniversary of the grant date.
Stakeholder Impact
- Shareholders: The equity award aligns the director's financial interests with the long-term performance of the company, potentially benefiting shareholders through improved governance and strategic decisions.
Next Steps
- Vesting of the 496 restricted share units on the sooner of the Issuer's 2026 annual shareholders' meeting or the first anniversary of the grant date.
Key Dates
| Date | Description |
|---|---|
| 07/29/2025 | Date of transaction for the acquisition of restricted share units. |
| 07/31/2025 | Date the Form 4 was signed by the attorney-in-fact. |
| 2026 | Approximate year of the Issuer's annual shareholders' meeting, which is a potential vesting date for the restricted share units. |
Keywords
HCA Healthcare, HCA, John Chidsey, Director, Equity Award, Restricted Share Units, RSUs, Insider Transaction, SEC Form 4, Corporate Governance
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.